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associated with HPV infection. Our recent report has shown that high-
risk HPV 16/18 infections were associated with female lung cancer 
incidences in Taiwan. To address the correlation between the different 
p53 genotypes, HPV infection and HPV oncoprotein expression in p53 
protein degradation of lung cancer, 60 health subjects and 141 primary 
lung cancer patients were included in this study. PCR-RFLP, nested-
PCR and immunohistochemial analysis were used to detect the p53 
codon 72 polymorphism, HPV 16/18 infection, HPV 16/18 E6 and p53 
protein expression. Immunohistochemistry data showed that HPV 16 or 
18 E6 protein was more frequently detected in female, adenocarcinoma, 
and nonsmoking lung tumors, compared with that of male, squamous 
cell carcinoma, and smoking lung tumors. Interestingly, HPV 16/18 E6 
expressions but not HPV 16/18 DNA were reversely correlated with 
p53 expression, which was further conﬁrmed by tissue in situ immu-
nostaining. Additionally, the frequency of p53 protein degradation in 
HPV 16/18 E6-positive/Arg homozygosity lung cancer tumors is much 
higher than that in the other three categorizes. This correlation was not 
found in HPV DNA infection. In conclusion, HPV 16/18 E6 proteins 
involvement in p53 inactivation to contribute to HPV-infected lung 
tumorigenesis is correlate with p53 genotypes.
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High Resolution Melting (HRM) analysis is an emergent technique that 
has enormous potential for the detection of DNA sequence changes. 
New instruments combined with next generation DNA intercalating 
dyes allow the discrimination of single base changes in PCR-ampli-
ﬁed products. The technology shows great promise for the detection of 
somatic mutations in clinical samples.
Clinical tumour samples present particular difﬁculties as the actual pro-
portion of tumour cells is highly variable and in many cases sequencing 
is not sufﬁciently sensitive to pick up the mutations. We developed as-
says to detect somatic gene mutations in exons 18-21 of the EGFR gene 
using HRM analysis. We also used assays for exon 2 of the KRAS gene 
and exon 20 of the HER2 gene. We validated these assays in a panel 
of 300 previously sequenced lung cancer biopsies. Sensitivity testing 
showed that the HRM assay was able to detect as little as 5% mutant 
sequence in a background of wild type DNA. HRM was able to readily 
detect sequence variation that was barely visible by sequencing leading 
to a lower rate of false negative results. These results demonstrate the 
utility of HRM analysis for the detection of somatic mutations in clini-
cal samples and for pre-screening of samples prior to sequencing. 
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We have shown that the thrombin Protease Activated Receptors PAR-1 
are expressed in primary cancer cells isolated from peritoneal and pleu-
ral malignant effusions (Oncogene 2005, 24: 8240-51). Here, our main 
goal was to evaluate several coagulation and thrombin activation ef-
fectors and markers in a series of 15 malignant effusions from patients 
with lung carcinomas (NSCLC, 11; SCLC, 4). All patients present a 
highly activated coagulation system in blood and their malignant effu-
sions, as indicated by high levels of prothrombin F1.2 fragments and 
D-dimers. Notably, we detected in the effusions all the coagulation fac-
tors of the tissue factor pathway inducing thrombin activation, namely 
factors FVII, FV, FX and FII, as well as high VEGF levels and IGF-II 
in mature and precursor forms. Fibrin clot formation also correlated 
with higher levels of free ionized calcium (iCa), suggesting that iCa 
and its binding protein albumin are regulatory factors for ﬁbrinogen-
esis in effusions. Consequently, thrombin, VEGF and IGF-II appear to 
converge in the promotion of survival and invasivity of the metastatic 
cancer cells from blood to the malignant effusions. Thus, we add new 
insights on the interconnections between blood coagulation disorders 
in cancer patients and thrombin activation in malignant effusions, 
including their functional interaction with PAR in metastatic cancer 
cells. Based upon these data we propose to counteract the metastatic 
cascades by targeted interaction with the coagulation system. Pos-
sible therapeutic approaches would be by the application of thrombin 
inhibitors, VEGF-directed antibodies, drugs targeting the VEGF and 
thrombin PAR signaling pathways such as thyrosin kinase or G-protein 
inhibitors. 
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Lung Cancer is a major chest problem in our society. It may present 
as a mass, pleural effusion, superior vena caval syndrome or a MUO 
(Metastasis of unknown origin). This study was carried out to analyze 
chromosomal patterns in lung cancer and assess its role as a diagnostic 
aid in certain clinical situations. 
25 patients entered the study. All underwent a detailed work up for 
the primary and metastatic lesions. Tissue samples were obtained by 
transthoracic ultrasound guided ﬁne needle aspiration (FNA)/ 18 of 
these were from the primary site the lung, 5 from metastatic nodes and 
1 from a pleural aspirate, 1 from pulmonary metastasis. The samples 
were processed directly in overnight / 24 hours cultures. Cell division 
was arrested at metaphase with colchicine (Boehringer 50ml of 100 ug 
/ ml) and analyzed after GTG banding (ISCN 1991). 
Metaphases were recovered in 14/25 patients. Cell poor aspirates were 
the reason for culture failures in the remainder. Of the 14 successful 
cultures, 9 were from the lung 8 NSCLC and 1 SCLC) and 3 from 
metastatic nodes (one small cell carcinoma and one poorly differentia-
